4/A: Twist Bioscience COO Sells Shares to Cover Tax Obligations

Twist Bioscience's President and COO, Patrick John Finn, sold 6,239 shares of common stock to cover tax obligations related to vesting Performance Stock Units.

Summary

• Patrick John Finn, President and COO of Twist Bioscience, sold 6,239 shares of common stock on November 6, 2024.
• The sale was executed at a price of $44.605 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of Performance Stock Units (PSUs).
• The sale was mandated by the company's equity incentive plan and does not represent a discretionary trade by Mr. Finn.
• This amended filing is to correct a footnote from the original filing on November 8, 2024.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to executive compensation and tax obligations, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Sales of shares to cover tax obligations are a standard practice for executives receiving equity compensation in publicly traded companies.
• Many companies use 'sell to cover' mechanisms to manage tax liabilities associated with vesting stock options or units.
• The number of shares sold and the price are within the typical range for such transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Twist Bioscience, stock sale, insider trading, Patrick John Finn, tax obligations, Performance Stock Units, equity incentive plan